The determination of causality of drug induced liver injury in patients with COVID-19 clinical syndrome.
Lina Mohammad NaseralallahBodoor Abdallah AboujabalNejat Mohamed GeryoAisha Al BoininFatima Al HattabRaza AkbarWaseem UmerLayla Abdul JabbarMohammed Ibn-Mas'ud DanjumaPublished in: PloS one (2022)
In a cohort of patients with COVID-19 clinical syndrome, we found the updated RUCAM scale to be useful in establishing "possible" or "probable" DILI likelihood as evident by the respective kappa values; this results if validated by larger sample sized studies will extend the clinical application of this universal tool for adjudication of DILI.